Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
In this update we added a new monograph for REMDESIVIR.
We also added new stability information to the monographs for EPINEPHRINE HYDROCHLORIDE and REMDESIVIR.
New compatibility information was added to the existing drug monograph FOR ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MORPHINE SULFATE, OCTREOTIDE ACETATE, PIPERACILLIN AND TAZOBACTAM, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.